Astra Zeneca gets nod for anticoagulant drug

AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses life-threatening or refractory bleeding associated with the use of Factor Xa (FXa) inhibitors, says a company statement.FXa inhibitors are...